NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
IranIranCoalitionMarchMilitaryTimelineEnergyDigestKoreaPlanSignificantGovernmentWednesdayEuropeEconomicPriceCrisisHormuzFaceStateTrumpMarketElectionOpenai
IranIranCoalitionMarchMilitaryTimelineEnergyDigestKoreaPlanSignificantGovernmentWednesdayEuropeEconomicPriceCrisisHormuzFaceStateTrumpMarketElectionOpenai
Source Articles

All Articles

Aggregated news from top global sources. Each article feeds our AI prediction pipeline.

​
​
Search: "semaglutide"

Relevant Predictions

View All
Generic Ozempic Poised to Reshape Global Obesity Market After Patent Expiry
GLP-1 Generic Competition
High

Generic Ozempic Poised to Reshape Global Obesity Market After Patent Expiry

8 predicted events · 9 sources

within 3 months
within 12-18 months
about 6 hours ago
India's GLP-1 Crackdown Signals Tighter Controls as Generic Boom Unfolds
India GLP-1 Regulation
High

India's GLP-1 Crackdown Signals Tighter Controls as Generic Boom Unfolds

6 predicted events · 5 sources

within 1-2 months
within 2-3 months
about 6 hours ago
Brazil's Weight-Loss Drug Market Set for Expansion After Patent Expiry
Semaglutide Patent Brazil
High

Brazil's Weight-Loss Drug Market Set for Expansion After Patent Expiry

6 predicted events · 7 sources

within 3 months
within 6 months
1 day ago
Eli Lilly's Triple-G Drug Poised to Reshape Obesity Market
Obesity Drug Competition
High

Eli Lilly's Triple-G Drug Poised to Reshape Obesity Market

6 predicted events · 5 sources

within 3-6 months
within 1-2 months
5 days ago
GLP-1 Discontinuation Study Poised to Reshape Treatment Guidelines
GLP-1 Treatment Continuity
High

GLP-1 Discontinuation Study Poised to Reshape Treatment Guidelines

5 predicted events · 6 sources

within 3-6 months
within 6-12 months
6 days ago

Relevant Digests

View All
Daily Health News Digest — Tuesday, March 10, 2026
Daily
Health

Daily Health News Digest — Tuesday, March 10, 2026

Fresh instability hits the FDA following leadership changes, while the agency increasingly avoids public advisory commit...

Tue, Mar 10
14 articles · 1 sources

Source Articles

Semaglutide for Weight Loss : Why Experts Stress Diet , Exercise Balance
indianexpress.com
about 13 hours ago

Semaglutide for Weight Loss : Why Experts Stress Diet , Exercise Balance

Published: 20260324T173000Z

Weight loss drug Ozempic cuts depression, anxiety, and addiction risk
Science Daily
3 days ago

Weight loss drug Ozempic cuts depression, anxiety, and addiction risk

GLP-1 medications like semaglutide (Ozempic) may offer unexpected mental health benefits alongside weight loss. A large study found major drops in depression, anxiety, and psychiatric-related hospital visits among users. Even substance use disorders were significantly lower during treatment. Researchers suspect both lifestyle improvements and direct brain effects could be at play.

Clustered
FDA approves higher dose of Wegovy
The Hill
6 days ago

FDA approves higher dose of Wegovy

The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg. The company says the higher dosage is recommended for those who taken the lower dose already for at least four weeks. Novo Nordisk...

Clustered
India’s weight-loss price war begins as semaglutide patent expires
South China Morning Post
6 days ago

India’s weight-loss price war begins as semaglutide patent expires

Namita Joshi made a New Year’s resolution in January to tackle one of her long-standing problems: being overweight. A key part of her slimming journey is her weekly weight-loss injections. While the 29-year-old interior designer has made changes to her diet and increased her workouts, she said the medication has helped her lose up to 6kg (13 pounds) in the past two months. With her weight at 85kg before her treatment and height at 1.65 metres (5.4 feet), Joshi was considered obese. “My mental...

Clustered
India's cheap weight-loss drugs could reshape global obesity fight
BBC World
7 days ago

India's cheap weight-loss drugs could reshape global obesity fight

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Clustered
Opinion: Semaglutide is going off-patent in India. But will people who need it be able to get it?
STAT News
8 days ago

Opinion: Semaglutide is going off-patent in India. But will people who need it be able to get it?

Rules determining who gets access to semaglutide in India were written for different bodies with different cardiovascular risks.

Clustered